I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma
The proposed study is a two-step trial with 1) a safety run in part conducted in pediatric patients and 2) a Phase II part in adult and pediatric patients aiming to evaluate the safety and clinical activity of atezolizumab + cobimetinib in advanced/metastatic soft tissue sarcomas.
measurable disease
epithelioid sarcomas
cobimetinib
neuropathy
aptt
- 0 views
- 19 Feb, 2024
- 4 locations
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.
measurable disease
alt/ast
neutrophil count
investigational treatment
gilbert's syndrome
- 0 views
- 19 Feb, 2024
- 4 locations